CAR-T cell therapy has revolutionised cancer treatment, offering life-changing outcomes for patients with haematological malignancies. Jean-Pierre Latere, PhD, CEO of EsoBiotec, discusses advances in in vivo engineering, which are poised to overcome manufacturing and cost barriers, making these therapies more accessible and expanding their potential applications. The landscape of cancer… Read More
In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this episode, Megan Thomas is in conversation with Shelley… Read More
Boston-based Ginkgo Bioworks, which is building a platform for cell programming and biosecurity, has launched Bioworks7, the latest expansion of its biological engineering foundry. With this new space, Ginkgo’s increased capacity will serve partners in cell and gene therapy, biomanufacturing and general mammalian programming for therapeutic applications… Read More
